The dark side of light: The damaging effects of UV rays and the protective efforts of MAP kinase signaling in the epidermis

DNA Repair

Volumn 3, Issue 6, 2004, Pages 567-580

  Hildesheim, Jeffrey ^a   Fornace Jr , Albert J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Keratinocyte; MAPK; Oncogene; Tumor suppressor; UV radiation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

CANCER INHIBITION; CARCINOGENESIS; DNA REPAIR; ENZYME ACTIVITY; EXCISION REPAIR; INFLAMMATION; KERATINOCYTE; MELANOMA; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SHORT SURVEY; SIGNAL TRANSDUCTION; SKIN CANCER; ULTRAVIOLET RADIATION;

DNA DAMAGE; EPIDERMIS; HUMANS; LIGHT; MITOGEN-ACTIVATED PROTEIN KINASES; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS;

EID: 2342561098     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2004.02.012     Document Type: Short Survey

References (189)

1. Epstein J.H. Photocarcinogenesis, skin cancer, and aging. J. Am. Acad. Dermatol. 9:1983;487-502
2. Kusewitt D.F., Budge C.L., Anderson M.M., Ryan S.L., Ley R.D. Frequency of ultraviolet radiation-induced mutation at the hprt locus in repair-proficient murine fibroblasts transfected with the denV gene of bacteriophage T4. Photochem. Photobiol. 58:1993;450-454
3. Ley R.D. Photoreactivation in humans. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4337
4. Setlow R.B. The wavelengths in sunlight effective in producing skin cancer: a theoretical analysis. Proc. Natl. Acad. Sci. U.S.A. 71:1974;3363-3366
5. Armstrong B.K., Kricker A. The epidemiology of UV induced skin cancer. J. Photochem. Photobiol. B. 63:2001;8-18
6. de Gruijl F.R. Skin cancer and solar UV radiation. Eur. J. Cancer. 35:1999;2003-2009
7. Woodhead A.D., Setlow R.B., Tanaka M. Environmental factors in nonmelanoma and melanoma skin cancer. J. Epidemiol. 9:1999;S102-S114
8. Miller D.L., Weinstock M.A. Nonmelanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol. 30:1994;774-778
9. Urbach F. Incidence of nonmelanoma skin cancer. Dermatol. Clin. 9:1991;751-755
10. de Gruijl F.R. Photocarcinogenesis: UVA vs. UVB. Methods Enzymol. 319:2000;359-366
11. Rosenstein B.S., Mitchell D.L. Action spectra for the induction of pyrimidine(6-4)pyrimidone photoproducts and cyclobutane pyrimidine dimers in normal human skin fibroblasts. Photochem. Photobiol. 45:1987;775-780
12. Ichibashi M., Ueda M., Budiyanto A., Bito T., Oka M., Fukunaga M., Tsuru K., Horikawa T. UV-induced skin damage. Toxicology. 189:2003;21-39
13. 2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured keratinocytes. J. Invest. Dermatol. 110:1998;966-971
14. Darr D., Fridovich I. Free radicals in cutaneous biology. J. Invest. Dermatol. 102:1994;671-675
15. Mitchell D.L. The relative cytotoxicity of (6-4) photoproducts and cyclobutane dimers in mammalian cells. Photochem. Photobiol. 48:1988;51-57
16. Clingen P.H., Arlett C.F., Cole J., Waugh A.P., Lowe J.E., Harcourt S.A., Hermanova N., Roza L., Mori T., Nikaido O., et al. Correlation of UVC and UVB cytotoxicity with the induction of specific photoproducts in T-lymphocytes and fibroblasts from normal human donors. Photochem. Photobiol. 61:1995;163-170
17. Eveno E., Bourre F., Quilliet X., Chevallier-Lagente O., Roza L., Eker A.P., Kleijer W.J., Nikaido O., Stefanini M., Hoeijmakers J.H., et al. Different removal of ultraviolet photoproducts in genetically related xeroderma pigmentosum and trichothiodystrophy diseases. Cancer Res. 55:1995;4325-4332
18. Nakagawa A., Kobayashi N., Muramatsu T., Yamashina Y., Shirai T., Hashimoto M.W., Ikenaga M., Mori T. Three-dimensional visualization of ultraviolet-induced DNA damage and its repair in human cell nuclei. J. Invest. Dermatol. 110:1998;143-148
19. Grossman D., Leffell D.J. The molecular basis of nonmelanoma skin cancer: new understanding. Arch. Dermatol. 133:1997;1263-1270
20. Daya-Grosjean L., Dumaz N., Sarasin A. The specificity of p53 mutation spectra in sunlight induced human cancers. J. Photochem. Photobiol. B. 28:1995;115-124
21. Yarosh D., Alas L.G., Yee V., Oberyszyn A., Kibitel J.T., Mitchell D., Rosenstein R., Spinowitz A., Citron M. Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. Cancer Res. 52:1992;4227-4231
22. Alcalay J., Freeman S.E., Goldberg L.H., Wolf J.E. Excision repair of pyrimidine dimers induced by simulated solar radiation in the skin of patients with basal cell carcinoma. J. Invest. Dermatol. 95:1990;506-509
23. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1614-1618
24. Cleaver J.E. Defective repair replication of DNA in xeroderma pigmentosum. Nature. 218:1968;652-656
25. Robbins J.H., Kraemer K.H., Lutzner M.A., Festoff B.W., Coon H.G. Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann. Intern. Med. 80:1974;221-248
26. Kraemer K.H. Sunlight and skin cancer: another link revealed. Proc. Natl. Acad. Sci. U.S.A. 94:1997;11-14
27. Yarosh D., Klein J., O'Connor A., Hawk J., Rafal E., Wolf P. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet. 357:2001;926-929
28. Schwarz A., Bhardwaj R., Aragane Y., Mahnke K., Riemann H., Metze D., Luger T.A., Schwarz T. Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J. Invest. Dermatol. 104:1995;922-927
29. Ziegler A., Jonason A.S., Leffell D.J., Simon J.A., Sharma H.W., Kimmelman J., Jacks T., Brash D.E. Sunburn and p53 in the onset of skin cancer. Nature. 372:1994;773-776
30. Danno K., Takigawa M., Horio T. Relationship of the cell cycle to sunburn cell formation. Photochem. Photobiol. 34:1981;203-206
31. Kulms D., Schwarz T. Molecular mechanisms of UV-induced apoptosis. Photodermatol. Photoimmunol. Photomed. 16:2000;195-201
32. Clydesdale G.J., Dandie G.W., Muller H.K. Ultraviolet light induced injury: immunological and inflammatory effects. Immunol. Cell. Biol. 79:2001;547-568
33. Schwarz A., Stander S., Berneburg M., Bohm M., Kulms D., van Steeg H., Grosse-Heitmeyer K., Krutmann J., Schwarz T. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat. Cell. Biol. 4:2002;26-31
34. Hwang B.J., Ford J.M., Hanawalt P.C., Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. U.S.A. 96:1999;424-428
35. Amundson S.A., Patterson A., Do K.T., Fornace A.J.J. A nucleotide excision repair master-switch: p53 regulated coordinate induction of global genomic repair genes. Cancer Biol. Ther. 1:2002;145-149
36. Smith M.L., Ford J.M., Hollander M.C., Bortnick R.A., Amundson S.A., Seo Y.R., Deng C.X., Hanawalt P.C., Fornace A.J.J. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Mol. Cell. Biol. 20:2000;3705-3714
37. Smith M.L., Chen I.T., Zhan Q., O'Connor P.M., Fornace A.J. Jr. Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene. 10:1995;1053-1059
38. Smith M.L., Fornace A.J. Jr. The two faces of tumor suppressor p53. Am. J. Pathol. 148:1996;1019-1022
39. Bernstein C., Bernstein H., Payne C.M., Garewal H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res. 511:2002;145-178
40. Fornace A.J.J., Nebert D.W., Hollander M.C., Luethy J.D., Papathanasiou M., Fargnoli J., Holbrook N.J. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol. 9:1989;4196-4203
41. Yarosh D.B., Alas L., Kibitel J., O'Connor A., Carrier F., Fornace A.J. Jr. Cyclobutane pryrimidine dimers in UV-DNA induce release of soluble mediators which activate the human immunodeficiency virus promoter. J. Invest. Dermatol. 100:1993;790-794
42. Eller M.S., Maeda T., Magnoni C., Atwal D., Gilchrest B.A. Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12627-12632
43. Devary Y., Rosette C., DiDonato J.A., Karin M. NF-κB activation by ultraviolet light not dependent on a nuclear signal. Science. 261:1993;1442-1445
44. Fisher G.J., Datta S.C., Talwar H.S., Wang Z.Q., Varani J., Kang S., Voorhees J.J. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 379:1996;335-339
45. Fornace A.J.J., Alamo I.J., Hollander M.C. DNA damage-inducible transcripts in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 85:1988;8800-8804
46. C. Koch-Paiz, S.A. Amundson, M.L. Bittner, P. Meltzer, A.J. Fornace, Jr., Functional genomics of UV radiation responses in human cells, Mutat Res, in press.
47. A.M. Bode, Z. Dong, Mitogen-activated protein kinase activation in UV-induced signal transduction, Sci. STKE, 2003, RE2.
48. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:2001;807-869
49. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell. Biol. 9:1997;180-186
50. Ip Y.T., Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell. Biol. 10:1998;205-219
51. Kyriakis J.M., Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays. 18:1996;567-577
52. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:2001;153-183
53. Boulton T.G., Nye S.H., Robbins D.J., Ip N.Y., Radziejewska E., Morgenbesser S.D., DePinho R.A., Panayotatos N., Cobb M.H., Yancopoulos G.D. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 65:1991;663-675
54. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1994;1025-1037
55. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160
56. Tibbles L.A., Woodgett J.R. The stress-activated protein kinase pathways. Cell. Mol. Life Sci. 55:1999;1230-1254
57. Canagarajah B.J., Khokhlatchev A., Cobb M.H., Goldsmith E.J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell. 90:1997;859-869
58. Crews C.M., Alessandrini A., Erikson R.L. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science. 258:1992;478-480
59. Zheng C.F., Guan K.L. Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2. J. Biol. Chem. 268:1993;11435-11439
60. Sanchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J., Kyriakis J.M., Zon L.I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature. 372:1994;794-798
61. Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., Davis R.J. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7337-7342
62. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., Davis R.J. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:1995;682-685
63. Coso O.A., Chiariello M., Yu J.C., Teramoto H., Crespo P., Xu N., Miki T., Gutkind J.S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell. 81:1995;1137-1146
64. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275:1997;90-94
65. Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M., Miyazono K., Ichijo H. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell. 2:1998;389-395
66. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331
67. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40
68. Wang W., Chen J.X., Liao R., Deng Q., Zhou J.J., Huang S., Sun P. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell. Biol. 22:2002;3389-3403
69. Iordanov M.S., Choi R.J., Ryabinina O.P., Dinh T.H., Bright R.K., Magun B.E. The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. Mol. Cell. Biol. 22:2002;5380-5394
70. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:1998;3008-3019
71. Hildesheim J., Belova G.I., Tyner S.D., Zhou X., Vardanian L., Fornace A.J. Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation. Oncogene. 23:2004;1829-1837
72. Hildesheim J., Fornace A.J.J. Gadd45a: an elusive yet attractive candidate gene in pancreatic cancer. Clin. Cancer Res. 8:2002;2475-2479
73. She Q.B., Ma W.Y., Zhong S., Dong Z. Activation of JNK1, RSK2, and MSK1 is involved in serine 112 phosphorylation of Bad by ultraviolet B radiation. J. Biol. Chem. 277:2002;24039-24048
74. She Q.B., Ma W.Y., Dong Z. Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20. Oncogene. 21:2000;1580-1589
75. Hildesheim J., Awwad R.T., Fornace A.J. p38 mitogen-activated protein kinase inhibitor protects the epidermis against the acute damaging effects of ultraviolet irradiation by blocking apoptosis and inflammatory responses. J. Invest. Dermatol. 122:2004;497-502
76. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., Bar-Sagi D., Jones S.N., Flavell R.A., Davis R.J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science. 288:2000;870-874
77. Graves L.M., Guy H.I., Kozlowski P., Huang M., Lazarowski E., Pope R.M., Collins M.A., Dahlstrand E.N., Earp H.S.R., Evans D.R. Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature. 403:2000;328-332
78. Treinies I., Paterson H.F., Hooper S., Marshall R.andC.J. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis. Mol. Cell. Biol. 19:1999;321-329
79. She Q.B., Chen N., Dong Z. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J. Biol. Chem. 275:2000;20444-20449
80. Shieh S.Y., Ahn J., Tamai K., Taya Y., Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14:2000;289-300
81. Saito S., Yamaguchi H., Higashimoto Y., Chao C., Xu Y., Fornace A.J.J., Appella E., Anderson C.W. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 278:2003;37536-37544
82. Takekawa M., Saito H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell. 95:1998;521-530
83. Mita H., Tsutsui J., Takekawa M., Witten E.A., Saito H. Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding. Mol. Cell. Biol. 22:2002;4544-4555
84. Abdollahi A., Lord K.A., Hoffman-Liebermann B., Liebermann D. Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines. Oncogene. 6:1991;165-167
85. Nakayama K., Hara T., Hibi M., Hirano T., Miyajima A. A novel oncostatin M-inducible gene OIG37 forms a gene family with MyD118 and GADD45 and negatively regulates cell growth. J. Biol. Chem. 274:1999;24766-24772
86. Zhang W., Bae I., Krishnaraju K., Azam N., Fan W., Smith K., Hoffman B., Liebermann D.A. CR6: a third member in the MyD118 and Gadd45 gene family which functions in negative growth control. Oncogene. 18:1999;4899-4907
87. Bulavin D.V., Kovalsky O., Hollander M.C., Fornace A.J.J. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol. Cell. Biol. 23:2003;3859-3871
88. Hunter T. Braking the cycle. Cell. 75:1993;839-841
89. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065
90. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825
91. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816
92. Xiong Y., Zhang H., Beach D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1993;1572-1583
93. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:1997;847-862
94. Cip1. Oncogene. 11:1995;1675-1683
95. Zhan Q., Antinore M.J., Wang X.W., Carrier F., Smith M.L., Harris C.C., Fornace A.J.J. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene. 18:1999;2892-2900
96. Ahmed N.U., Ueda M., Ichihashi M. Induced expression of p16 and p21 proteins in UVB-irradiated human epidermis and cultured keratinocytes. J. Dermatol. Sci. 19:1999;175-181
97. Pavey S., Conroy S., Russell T., Gabrielli B. Ultraviolet radiation induces p16CDKN2A expression in human skin. Cancer Res. 59:1999;4185-4189
98. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:1993;704-707
99. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S.V., Stockert E., Day R.S. III, Johnson B.E., Skolnick M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440
100. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., Carson D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 368:1994;753-756
101. Ortega S., Malumbres M., Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta. 1602:2002;73-87
102. Goloudina A., Yamaguchi H., Chervyakova D.B., Appella E., Fornace A.J.J., Bulavin D.V. Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint. Cell Cycle. 2:2003;473-478
103. Bulavin D.V., Higashimoto Y., Popoff I.J., Gaarde W.A., Basrur V., Potapova O., Appella E., Fornace A.J. Jr. Initiation of a G2/M checkpoint after UV radiation requires p38 kinase. Nature. 411:2001;102-107
104. Milligan A., Gabrielli B.G., Clark J.M., Hayward N.K., Ellem K.A. Involvement of p16CDKN2A in cell cycle delays after low dose UV irradiation. Mutat. Res. 422:1998;43-53
105. Giles R.H., van Es J.H., Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta. 1653:2003;1-24
106. Ehrhart J.C., Gosselet F.P., Culerrier R.M., Sarasin A. UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis. Photochem. Photobiol. Sci. 2:2003;825-834
107. Patturajan M., Nomoto S., Sommer M., Fomenkov A., Hibi K., Zangen R., Poliak N., Califano J., Trink B., Ratovitski E., Sidransky D. DeltaNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell. 1:2002;369-379
108. Brabletz T., Jung A., Dag S., Hlubek F., Kirchner T. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol. 155:1999;1033-1038
109. Crawford H.C., Fingleton B.M., Rudolph-Owen L.A., Goss K.J., Rubinfeld B., Polakis P., Matrisian L.M. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene. 18:1999;2883-2891
110. Morin P.J. Beta-catenin signaling and cancer. Bioessays. 21:1999;1021-1030
111. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U.S.A. 96:1999;5522-5527
112. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426
113. Behrens J. Control of beta-catenin signaling in tumor development. Ann. N. Y. Acad. Sci. 910:2000;21-33. discussion 33-5
114. Takahashi M., Tsunoda T., Seiki M., Nakamura Y., Furukawa Y. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene. 21:2002;5861-5867
115. Carter S., Auer K.L., Reardon D.B., Birrer M., Fisher P.B., Valerie K., Schmidt-Ullrich R., Mikkelsen R., Dent P. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose radiation in A431 human squamous carcinoma cells. Oncogene. 16:1998;2787-2796
116. Brash D.E., Rudolph J.A., Simon J.A., Lin A., McKenna G.J., Baden H.P., Halperin A.J., Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10124-10128
117. Ziegler A., Leffell D.J., Kunala S., Sharma H.W., Gailani M., Simon J.A., Halperin A.J., Baden H.P., Shapiro P.E., Bale A.E., Et A. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4216-4220
118. Basset-Seguin N., Moles J.P., Mils V., Dereure O., Guilhou J.J. TP53 tumor suppressor gene and skin carcinogenesis. J. Invest. Dermatol. 103:1994;102S-106S
119. Brash D.E., Ziegler A., Jonason A.S., Simon J.A., Kunala S., Leffell D.J. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J. Invest. Dermatol. Symp. Proc. 1:1996;136-142
120. Nagano T., Ueda M., Ichihashi M. Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Arch. Dermatol. 129:1993;1157-1161
121. Taguchi M., Watanabe S., Yashima K., Murakami Y., Sekiya T., Ikeda S. Aberrations of the tumor suppressor p53 gene and p53 protein in solar keratosis in human skin. J. Invest. Dermatol. 103:1994;500-503
122. Ouhtit A., Ueda M., Nakazawa H., Ichihashi M., Dumaz N., Sarasin A., Yamasaki H. Quantitative detection of ultraviolet-specific p53 mutations in normal skin from Japanese patients. Cancer Epidemiol. Biomarkers Prev. 6:1997;433-438
123. Ling G., Persson A., Berne B., Uhlen M., Lundeberg J., Ponten F. Persistent p53 mutations in single cells from normal human skin. Am. J. Pathol. 159:2001;1247-1253
124. Bishop D.T., Demenais F., Goldstein A.M., Bergman W., Bishop J.N., Bressac-de Paillerets B., Chompret A., Ghiorzo P., Gruis N., Hansson J., Harland M., Hayward N., Holland E.A., Mann G.J., Mantelli M., Nancarrow D., Platz A., Tucker M.A. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl. Cancer Inst. 94:2002;894-903
125. Bressac-de-Paillerets B., Avril M.F., Chompret A., Demenais F. Genetic and environmental factors in cutaneous malignant melanoma. Biochimie. 84:2002;67-74
126. Soufir N., Daya-Grosjean L., de La Salmoniere P., Moles J.P., Dubertret L., Sarasin A., Basset-Seguin N. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients. J. Natl. Cancer Inst. 92:2000;1841-1847
127. Soufir N., Ribojad M., Magnaldo T., Thibaudeau O., Delestaing G., Daya-Grosjean L., Rivet J., Sarasin A., Basset-Seguin N. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient. J. Invest. Dermatol. 119:2002;1355-1360
128. Greenhalgh D.A., Rothnagel J.A., Quintanilla M.I., Orengo C.C., Gagne T.A., Bundman D.S., Longley M.A., Roop D.R. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol. Carcinog. 7:1993;99-110
129. van der Schroeff J.G., Evers L.M., Boot A.J., Bos J.L. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J. Invest. Dermatol. 94:1990;423-425
130. Pierceall W.E., Goldberg L.H., Tainsky M.A., Mukhopadhyay T., Ananthaswamy H.N. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol. Carcinog. 4:1991;196-202
131. Quintanilla M., Brown K., Ramsden M., Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature. 322:1986;78-80
132. Yamasawa K., Nio Y., Dong M., Yamaguchi K., Itakura M. Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer. Clin. Cancer Res. 8:2002;2563-2569
133. Liefer K.M., Koster M.I., Wang X.J., Yang A., McKeon F., Roop D.R. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res. 60:2000;4016-4020
134. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dotsch V., Andrews N.C., Caput D., McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell. 2:1998;305-316
135. Mills A.A., Zheng B., Wang X.J., Vogel H., Roop D.R., Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 398:1999;708-713
136. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R.T., Tabin C., Sharpe A., Caput D., Crum C., McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 398:1999;714-718
137. Parsa R., Yang A., McKeon F., Green H. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J. Invest. Dermatol. 113:1999;1099-1105
138. Park B.J., Lee S.J., Kim J.I., Lee S.J., Lee C.H., Chang S.G., Park J.H., Chi S.G. Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res. 60:2000;3370-3374
139. Yamaguchi K., Wu L., Caballero O.L., Hibi K., Trink B., Resto V., Cairns P., Okami K., Koch W.M., Sidransky D., Jen J. Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int. J. Cancer. 86:2000;684-689
140. Hu H., Xia S.H., Li A.D., Xu X., Cai Y., Han Y.L., Wei F., Chen B.S., Huang X.P., Han Y.S., Zhang J.W., Zhang X., Wu M., Wang M.R. Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int. J. Cancer. 102:2002;580-583
141. Pelosi G., Pasini F., Olsen S.C., Pastorino U., Maisonneuve P., Sonzogni A., Maffini F., Pruneri G., Fraggetta F., Cavallon A., Roz E., Iannucci A., Bresaola E., Viale G. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas. J. Pathol. 198:2002;100-109
142. Urist M.J., Di C.C.J., Lu M.L., Charytonowicz E., Verbel D., Crum C.P., Ince T.A., McKeon F.D., Cordon-Cardo C. Loss of p63 expression is associated with tumor progression in bladder cancer. Am. J. Pathol. 161:2002;1199-1206
143. Westfall M.D., Mays D.J., Sniezek J.C., Pietenpol J.A. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell. Biol. 23:2003;2264-2276
144. King K.E., Ponnamperuma R.M., Yamashita T., Tokino T., Lee L.A., Young M.F., Weinberg W.C. deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. Oncogene. 22:2003;3635-3644
145. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science. 287:2000;1606-1609
146. Polakis P. Wnt signaling and cancer. Genes Dev. 14:2000;1837-1851
147. Moon R.T., Bowerman B., Boutros M., Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science. 296:2002;1644-1646
148. van E.J.H., Barker N., Clevers H. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr. Opin. Genet. Dev. 13:2003;28-33
149. Kripke M.L. Immunologic mechanisms in UV radiation carcinogenesis. Adv. Cancer Res. 34:1981;69-106
150. Daynes R.A., Bernhard E.J., Gurish M.F., Lynch D.H. Experimental photoimmunology: immunologic ramifications of UV-induced carcinogenesis. J. Invest. Dermatol. 77:1981;77-85
151. Yoshikawa T., Rae V., Bruins-Slot W., Van den Berg J.W., Taylor J.R., Streilein J.W. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J. Invest. Dermatol. 95:1990;530-536
152. Streilein J.W., Taylor J.R., Vincek V., Kurimoto I., Shimizu T., Tie C., Golomb C. Immune surveillance and sunlight-induced skin cancer. Immunol. Today. 15:1994;174-179
153. Kripke M.L., Cox P.A., Alas L.G., Yarosh D.B. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7516-7520
154. Soter N.A. Acute effects of ultraviolet radiation on the skin. Semin. Dermatol. 9:1990;11-15
155. Afaq F., Mukhtar H. Effects of solar radiation on cutaneous detoxification pathways. J. Photochem. Photobiol. B. 63:2001;61-69
156. Enk A.H., Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1398-1402
157. Ansel J., Perry P., Brown J., Damm D., Phan T., Hart C., Luger T., Hefeneider S. Cytokine modulation of keratinocyte cytokines. J. Invest. Dermatol. 94:1990;101S-107S
158. Luger T.A., Schwarz T. Evidence for an epidermal cytokine network. J. Invest. Dermatol. 95:1990;100S-104S
159. Lee J.C., Young P.R. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukoc. Biol. 59:1996;152-157
160. Beyaert R., Cuenda A., Vanden Berghe W., Plaisance S., Lee J.C., Haegeman G., Cohen P., Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15:1996;1914-1923
161. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273:1998;3285-3290
162. Wery-Zennaro S., Zugaza J.L., Letourneur M., Bertoglio J., Pierre J. IL-4 regulation of IL-6 production involves Rac/Cdc42- and p38 MAPK-dependent pathways in keratinocytes. Oncogene. 19:2000;1596-1604
163. Cooper K.D., Oberhelman L., Hamilton T.A., Baadsgaard O., Terhune M., LeVee G., Anderson T., Koren H. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc. Natl. Acad. Sci. U.S.A. 89:1992;8497-8501
164. Weimar V.M., Ceilley R.I., Goeken J.A. Cell-mediated immunity in patients with basal and squamous cell skin cancer. J. Am. Acad. Dermatol. 2:1980;143-147
165. Rosette C., Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science. 274:1996;1194-1197
166. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178
167. Boldin M.P., Varfolomeev E.E., Pancer Z., Mett I.L., Camonis J.H., Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:1995;7795-7798
168. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505-512
169. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815
170. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H., Peter M.E., Dixit V.M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:1996;817-827
171. Chinnaiyan A.M., Tepper C.G., Seldin M.F., O'Rourke K., Kischkel F.C., Hellbardt S., Krammer P.H., Peter M.E., Dixit V.M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:1996;4961-4965
172. Aragane Y., Kulms D., Metze D., Wilkes G., Poppelmann B., Luger T.A., Schwarz T. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J. Cell. Biol. 140:1998;171-182
173. Hill L.L., Ouhtit A., Loughlin S.M., Kripke M.L., Ananthaswamy H.N., Owen-Schaub L.B. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science. 285:1999;898-900
174. Ouhtit A., Gorny A., Muller H.K., Hill L.L., Owen-Schaub L., Ananthaswamy H.N. Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesis. Am. J. Pathol. 157:2000;1975-1981
175. Hsu S.C., Gavrilin M.A., Tsai M.H., Han J., Lai M.Z. p38 mitogen-activated protein kinase is involved in Fas ligand expression. J. Biol. Chem. 274:1999;25769-25776
176. Denning M.F., Wang Y., Tibudan S., Alkan S., Nickoloff B.J., Qin J.Z. Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ. 9:2002;40-52
177. Zou H., Li Y., Liu X., Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:1999;11549-11556
178. Saleh A., Srinivasula S.M., Balkir L., Robbins P.D., Alnemri E.S. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell. Biol. 2:2000;476-483
179. Stennicke H.R., Deveraux Q.L., Humke E.W., Reed J.C., Dixit V.M., Salvesen G.S. Caspase-9 can be activated without proteolytic processing. J. Biol. Chem. 274:1999;8359-8362
180. Renatus M., Stennicke H.R., Scott F.L., Liddington R.C., Salvesen G.S. Dimer formation drives the activation of the cell death protease caspase 9. Proc. Natl. Acad. Sci. U.S.A. 98:2001;14250-14255
181. Sitailo L.A., Tibudan S.S., Denning M.F. Activation of caspase-9 is required for UV-induced apoptosis of human keratinocytes. J. Biol. Chem. 277:2002;19346-19352
182. Rodriguez-Villanueva J., Greenhalgh D., Wang X.J., Bundman D., Cho S., Delehedde M., Roop D., McDonnell T.J. Human keratin-1 bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation. Oncogene. 16:1998;853-863
183. Pena J.C., Fuchs E., Thompson C.B. Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. Cell Growth Differ. 8:1997;619-629
184. Rossiter H., Beissert S., Mayer C., Schon M.P., Wienrich B.G., Tschachler E., Kupper T.S. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis. Cancer Res. 61:2001;3619-3626
185. Taylor J.K., Zhang Q.Q., Monia B.P., Marcusson E.G., Dean N.M. Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli. Oncogene. 18:1999;4495-4504
186. Gillardon F., Moll I., Meyer M., Michaelidis T.M. Alterations in cell death and cell cycle progression in the UV-irradiated epidermis of bcl-2-deficient mice. Cell Death Differ. 6:1999;55-60
187. Lo Muzio L., Staibano S., Pannone G., Mignogna M.D., Mariggio A., Salvatore G., Chieffi P., Tramontano D., De Rosa G., Altieri D.C. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp. Mol. Pathol. 70:2001;249-254
188. Grossman D., Kim P.J., Blanc-Brude O.P., Brash D.E., Tognin S., Marchisio P.C., Altieri D.C. Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J. Clin. Invest. 108:2001;991-999
189. Chiodino C., Cesinaro A.M., Ottani D., Fantini F., Giannetti A., Trentini G.P., Pincelli C. Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J. Invest. Dermatol. 113:1999;415-418